We found a significantly higher inflammatory response in AILD patients than in HCs, as shown by significantly higher IL-1β, IL-8 TNF-α, IFN-γ, MIP-1β and secretory IgA levels. The gene discussed is CD79A; the disease is angioimmunoblastic T-cell lymphoma.